GlassScriptPhysician profile
Christopher S Gomez
NPI 1699926238
$12,513.02
in general payments reported to CMS, 2019-2025
21 companies · $1,966 in 2025
The $1,966 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,323 · 2020: $778 · 2021: $1,152 · 2022: $1,894 · 2023: $1,159 · 2024: $4,241 · 2025: $1,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $2,715 · Travel and Lodging: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $2,715.33 |
| Travel and Lodging | $1,650.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,105.42 | 2024-2025 | |
| Medtronic, INC. | $2,557.40 | 2021-2025 | Interstim |
| 180 Medical, INC. | $1,567.93 | 2019-2025 | Gentlecath, Gentlecath Glide |
| Medtronic USA, INC. | $1,164.12 | 2019-2020 | |
| Procept Biorobotics Corporation | $835.38 | 2020-2025 | Aquabeam System |
| Boston Scientific Corporation | $798.43 | 2019-2025 | Ams 700 |
| Convatec INC. | $297.17 | 2021-2023 | |
| Astellas Pharma US INC | $151.43 | 2022-2024 | Myrbetriq |
| Acerus Pharmaceuticals Corporation | $146.67 | 2021 | |
| Progenics Pharmaceuticals, INC. | $140.87 | 2024 | |
| Teleflex LLC | $139.02 | 2022 | |
| Laborie Medical Technologies Corp. | $137.21 | 2019 | |
| Allergan, INC. | $127.15 | 2019 | |
| Coloplast Corp | $113.06 | 2019-2020 | |
| Neotract INC. | $55.33 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $37.14 | 2022-2023 | Prolaris |
| Hollister Incorporated | $35.55 | 2021 | |
| Stimwave Technologies Incorporated | $34.56 | 2019 | |
| Axonics, INC. | $24.07 | 2023 | Axonics |
| Urogen Pharma, INC. | $23.07 | 2025 | |
| Novartis Pharmaceuticals Corporation | $22.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.